We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota. Organised in collaboration with the ISA Board and members of Mayo Clinic, the program promises to be both informative and engaging.

The symposium will feature a comprehensive scientific program covering various types of systemic amyloidosis, including ATTR (hereditary and wild-type), AL (light-chain), AA, and less frequent forms.

The program will delve into the basic science, pathophysiology, diagnosis, and current and emerging treatments of systemic amyloidosis. Participants will have the opportunity to learn from competitive oral and poster abstracts, gaining insights into the latest advancements in the field.

We encourage you to join Dr. Taubel and other experts in the field for what promises to be an enlightening and educational experience. 

To find out more: https://cveducation.mayo.edu/store/international-symposium-on-amyloidosis 

Latest news

How Richmond Pharmacology Supports Sponsors Navigating ICH E6 (R3)

February 5, 2026
The updated ICH E6 (R3) guideline places greater emphasis on proportionality, risk-based oversight...
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event